IP Saline bolus and infusion — Competitive Intelligence Brief

IP Saline bolus and infusion (IP Saline bolus and infusion) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Crystalloid fluid / Electrolyte replacement. Area: Critical Care / Emergency Medicine / General Supportive Care.

marketed Crystalloid fluid / Electrolyte replacement Critical Care / Emergency Medicine / General Supportive Care Small molecule

Target snapshot

IP Saline bolus and infusion (IP Saline bolus and infusion) — University of Auckland, New Zealand. IP saline bolus and infusion delivers isotonic sodium chloride solution intravenously to restore fluid and electrolyte balance.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
IP Saline bolus and infusion TARGET	IP Saline bolus and infusion	University of Auckland, New Zealand	marketed	Crystalloid fluid / Electrolyte replacement
normal saline - injection	normal saline - injection	Montefiore Medical Center	marketed	Crystalloid fluid / Electrolyte replacement solution
Saline Solution (NaCl 0,9%)	Saline Solution (NaCl 0,9%)	Université du Québec à Trois-Rivières	marketed	Crystalloid fluid / Electrolyte replacement
Sodium Chloride 0.9% infusion	Sodium Chloride 0.9% infusion	Hospital Central "Dr. Ignacio Morones Prieto"	marketed	Crystalloid fluid / Electrolyte replacement solution
Sodium Chloride [0.9%]	Sodium Chloride [0.9%]	Fundacion Clinica Valle del Lili	marketed	Crystalloid fluid / Electrolyte replacement
Sodium Chloride 0.9% Inj	Sodium Chloride 0.9% Inj	Dalarna County Council, Sweden	marketed	Crystalloid fluid / Electrolyte replacement
saline 09%	saline 09%	Vinmec Healthcare System	marketed	Crystalloid fluid / Electrolyte replacement solution

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Crystalloid fluid / Electrolyte replacement class)

1. University of Auckland, New Zealand · 2 drugs in this class
2. Fundacion Clinica Valle del Lili · 1 drug in this class
3. Montefiore Medical Center · 1 drug in this class
4. Rhode Island Hospital · 1 drug in this class
5. Rigshospitalet, Denmark · 1 drug in this class
6. Seoul National University Hospital · 1 drug in this class
7. Universidad Nacional de La Plata · 1 drug in this class
8. University of Nottingham · 1 drug in this class
9. Dalarna County Council, Sweden · 1 drug in this class
10. Université du Québec à Trois-Rivières · 1 drug in this class